
C4U is a bio-venture company originated from The University of Osaka, established in 2018 for the practical application of the novel genome editing technology CRISPR-Cas3 technology. CRISPR-Cas3 technology has strengths, such as its ability to induce large-scale deletions of DNA, its superior safety profile due to less concern about off-target deletion expression, and its freedom to operate (FTO) under patents. C4U is currently conducting research and improvements to establish this technology as a genome editing platform that enables both knock-out and knock-in, and is expected to be utilised…
Annual Revenue$10M to $25M
Estimated OwnershipPrivateBuilt from contact records that share this company: name, job title, job level, job function and person location.
Turn cold outreach into meaningful business conversations.
Rated and recommended by professionals who expect more
Matching runs on fields we already have: industry, employee range, HQ location, ownership type, funding rounds, specialities. Results come live from the ReachStream directory.